Brief: Lemonaid Health Now Offering Glp-1 Medication Through Weight Loss Membership Program
Aug 28 (Reuters) - 23andMe Holding Co. ME.O :
* LEMONAID HEALTH NOW OFFERING GLP-1 MEDICATION THROUGH
WEIGHT
LOSS MEMBERSHIP PROGRAM
* LEMONAID HEALTH: OFFERING OZEMPIC, WEGOVY, COMPOUNDED
SEMAGLUTIDE THROUGH WEIGHT LOSS PROGRAM ON TELEHEALTH PLATFORM
Source text for Eikon: ID:nGNX7dlPbT
Further company coverage: ME.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Chrome Holding Co
See all newsBrief: Chrome Holding Co Enters Into Stock Purchase Agreement With Bambu Ventures
23andMe seeks approval of larger, $50 million data breach settlement
Brief: 23andMe Holding Co Changes Name to Chrome Holding Co
Brief: 23andMe Holding Says Debtors Repay All Outstanding Indebtedness, Terminate Loan Agreement
founder